Ashburton (Jersey) LTD Novartis Ag Transaction History

Ashburton (Jersey) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Apr 26, 2023	SELL	$74.61 - $87.26 $45,362 - $53,054	-608 Closed	0 $0
Q4 2020 May 23, 2023	BUY	$78.07 - $94.43 $47,466 - $57,413	608 New	608 $57,000
Q4 2018 Feb 28, 2019	BUY	$73.66 - $82.02 $44,785 - $49,868	608 New	608 $52,000
Q4 2018 Feb 04, 2019	SELL	$73.66 - $82.02 $44,785 - $49,868	-608 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$66.94 - $77.43 $40,699 - $47,077	608 New	608 $52,000

1,439

135M

1.12M

1.82M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ashburton (Jersey) LTD, based on Form 13F filings with the SEC.

Stay updated on Ashburton (Jersey) LTD with notifications on news.